Feinberg, B., Burruss, R., Traurig, T., & Drenning, J. (2015). PHS89 - Impact of Patient reported outcomes on Medication Therapy Management for High-Cost Specialty Drugs. Value in Health, 18(3), A262. https://doi.org/10.1016/j.jval.2015.03.1528
Chicago Style (17th ed.) CitationFeinberg, B.A, R. Burruss, T. Traurig, and J. Drenning. "PHS89 - Impact of Patient Reported Outcomes on Medication Therapy Management for High-Cost Specialty Drugs." Value in Health 18, no. 3 (2015): A262. https://doi.org/10.1016/j.jval.2015.03.1528.
MLA (9th ed.) CitationFeinberg, B.A, et al. "PHS89 - Impact of Patient Reported Outcomes on Medication Therapy Management for High-Cost Specialty Drugs." Value in Health, vol. 18, no. 3, 2015, p. A262, https://doi.org/10.1016/j.jval.2015.03.1528.